It is possible that cholesterol overload in hepatocytes in familial hypercholesterolemia (FH) and/or the diminished LDLR activity itself may enhance hepatic secretion of apoB, as observed in FH patients with LDLR mutation. This evidence concerns the gene APOB and familial hyperaldosteronism.